 | • レポートコード：D0804-09695 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、患者用制御インジェクターの世界市場を広く調査・分析し、今後の市場展望をまとめております。患者用制御インジェクターの種類別市場規模（電子式インジェクター、機械式インジェクター、その他）、用途別市場規模（がん治療、自己免疫治療、血液疾患治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：West Pharmaceutical Services, Inc.、Roche、Unilife Corporation、Sensile Medical、Westbourne Medical Ltd.、Janssen Pharmaceutical (Johnson & Johnson) ・地域別グローバル市場分析 2015年-2020年 ・患者用制御インジェクターの北米市場（アメリカ、カナダ、メキシコ） ・患者用制御インジェクターのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・患者用制御インジェクターのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・患者用制御インジェクターの南米市場（ブラジル、アルゼンチン） ・患者用制御インジェクターの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：電子式インジェクター、機械式インジェクター、その他 ・用途別分析：がん治療、自己免疫治療、血液疾患治療、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Patient Controlled Injectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Patient Controlled Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Patient Controlled Injectors market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Patient Controlled Injectors market has been segmented into
Electronical Injectors
Mechanical Injectors
Others
By Application, Patient Controlled Injectors has been segmented into:
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Patient Controlled Injectors market presented in the report. This section sheds light on the sales growth of different regional and country-level Patient Controlled Injectors markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Patient Controlled Injectors market.
The report offers in-depth assessment of the growth and other aspects of the Patient Controlled Injectors market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Patient Controlled Injectors Market Share Analysis
Patient Controlled Injectors competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Patient Controlled Injectors sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Patient Controlled Injectors sales, revenue and market share for each player covered in this report.
The major players covered in Patient Controlled Injectors are:
West Pharmaceutical Services, Inc.
Roche
Unilife Corporation
Sensile Medical
Westbourne Medical Ltd.
Janssen Pharmaceutical (Johnson & Johnson)
Among other players domestic and global, Patient Controlled Injectors market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Patient Controlled Injectors product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Patient Controlled Injectors, with price, sales, revenue and global market share of Patient Controlled Injectors in 2018 and 2019.
Chapter 3, the Patient Controlled Injectors competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Patient Controlled Injectors breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Patient Controlled Injectors market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Patient Controlled Injectors sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Patient Controlled Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Patient Controlled Injectors Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Patient Controlled Injectors Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer Treatment
1.3.3 Auto-immune Treatment
1.3.4 Blood Disorders Treatment
1.3.5 Others
1.4 Overview of Global Patient Controlled Injectors Market
1.4.1 Global Patient Controlled Injectors Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 West Pharmaceutical Services, Inc.
2.1.1 West Pharmaceutical Services, Inc. Details
2.1.2 West Pharmaceutical Services, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 West Pharmaceutical Services, Inc. SWOT Analysis
2.1.4 West Pharmaceutical Services, Inc. Product and Services
2.1.5 West Pharmaceutical Services, Inc. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Unilife Corporation
2.3.1 Unilife Corporation Details
2.3.2 Unilife Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Unilife Corporation SWOT Analysis
2.3.4 Unilife Corporation Product and Services
2.3.5 Unilife Corporation Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sensile Medical
2.4.1 Sensile Medical Details
2.4.2 Sensile Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sensile Medical SWOT Analysis
2.4.4 Sensile Medical Product and Services
2.4.5 Sensile Medical Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Westbourne Medical Ltd.
2.5.1 Westbourne Medical Ltd. Details
2.5.2 Westbourne Medical Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Westbourne Medical Ltd. SWOT Analysis
2.5.4 Westbourne Medical Ltd. Product and Services
2.5.5 Westbourne Medical Ltd. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Janssen Pharmaceutical (Johnson & Johnson)
2.6.1 Janssen Pharmaceutical (Johnson & Johnson) Details
2.6.2 Janssen Pharmaceutical (Johnson & Johnson) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Janssen Pharmaceutical (Johnson & Johnson) SWOT Analysis
2.6.4 Janssen Pharmaceutical (Johnson & Johnson) Product and Services
2.6.5 Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Patient Controlled Injectors Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Patient Controlled Injectors Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Patient Controlled Injectors Manufacturer Market Share in 2019
3.3.2 Top 6 Patient Controlled Injectors Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Patient Controlled Injectors Sales, Revenue and Market Share by Regions
4.1.1 Global Patient Controlled Injectors Sales and Market Share by Regions (2015-2020)
4.1.2 Global Patient Controlled Injectors Revenue and Market Share by Regions (2015-2020)
4.2 North America Patient Controlled Injectors Sales and Growth Rate (2015-2020)
4.3 Europe Patient Controlled Injectors Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Patient Controlled Injectors Sales and Growth Rate (2015-2020)
4.5 South America Patient Controlled Injectors Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Patient Controlled Injectors Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Patient Controlled Injectors Sales, Revenue and Market Share by Country
5.1.1 North America Patient Controlled Injectors Sales and Market Share by Country (2015-2020)
5.1.2 North America Patient Controlled Injectors Revenue and Market Share by Country (2015-2020)
5.2 United States Patient Controlled Injectors Sales and Growth Rate (2015-2020)
5.3 Canada Patient Controlled Injectors Sales and Growth Rate (2015-2020)
5.4 Mexico Patient Controlled Injectors Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Patient Controlled Injectors Sales, Revenue and Market Share by Country
6.1.1 Europe Patient Controlled Injectors Sales and Market Share by Country (2015-2020)
6.1.2 Europe Patient Controlled Injectors Revenue and Market Share by Country (2015-2020)
6.2 Germany Patient Controlled Injectors Sales and Growth Rate (2015-2020)
6.3 UK Patient Controlled Injectors Sales and Growth Rate (2015-2020)
6.4 France Patient Controlled Injectors Sales and Growth Rate (2015-2020)
6.5 Russia Patient Controlled Injectors Sales and Growth Rate (2015-2020)
6.6 Italy Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Patient Controlled Injectors Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Patient Controlled Injectors Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Patient Controlled Injectors Revenue and Market Share by Regions (2015-2020)
7.2 China Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7.3 Japan Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7.4 Korea Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7.5 India Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Patient Controlled Injectors Sales and Growth Rate (2015-2020)
7.7 Australia Patient Controlled Injectors Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Patient Controlled Injectors Sales, Revenue and Market Share by Country
8.1.1 South America Patient Controlled Injectors Sales and Market Share by Country (2015-2020)
8.1.2 South America Patient Controlled Injectors Revenue and Market Share by Country (2015-2020)
8.2 Brazil Patient Controlled Injectors Sales and Growth Rate (2015-2020)
8.3 Argentina Patient Controlled Injectors Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Patient Controlled Injectors Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Patient Controlled Injectors Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Patient Controlled Injectors Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Patient Controlled Injectors Sales and Growth Rate (2015-2020)
9.3 Turkey Patient Controlled Injectors Sales and Growth Rate (2015-2020)
9.4 Egypt Patient Controlled Injectors Sales and Growth Rate (2015-2020)
9.5 South Africa Patient Controlled Injectors Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Patient Controlled Injectors Sales and Market Share by Type (2015-2020)
10.2 Global Patient Controlled Injectors Revenue and Market Share by Type (2015-2020)
10.3 Global Patient Controlled Injectors Price by Type (2015-2020)
11 Global Patient Controlled Injectors Market Segment by Application
11.1 Global Patient Controlled Injectors Sales Market Share by Application (2015-2020)
11.2 Global Patient Controlled Injectors Revenue Market Share by Application (2015-2020)
11.3 Global Patient Controlled Injectors Price by Application (2015-2020)
12 Market Forecast
12.1 Global Patient Controlled Injectors Sales, Revenue and Growth Rate (2021-2025)
12.2 Patient Controlled Injectors Market Forecast by Regions (2021-2025)
12.2.1 North America Patient Controlled Injectors Market Forecast (2021-2025)
12.2.2 Europe Patient Controlled Injectors Market Forecast (2021-2025)
12.2.3 Asia-Pacific Patient Controlled Injectors Market Forecast (2021-2025)
12.2.4 South America Patient Controlled Injectors Market Forecast (2021-2025)
12.2.5 Middle East & Africa Patient Controlled Injectors Market Forecast (2021-2025)
12.3 Patient Controlled Injectors Market Forecast by Type (2021-2025)
12.3.1 Global Patient Controlled Injectors Sales Forecast by Type (2021-2025)
12.3.2 Global Patient Controlled Injectors Market Share Forecast by Type (2021-2025)
12.4 Patient Controlled Injectors Market Forecast by Application (2021-2025)
12.4.1 Global Patient Controlled Injectors Sales Forecast by Application (2021-2025)
12.4.2 Global Patient Controlled Injectors Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Patient Controlled Injectors Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Patient Controlled Injectors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Patient Controlled Injectors Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. West Pharmaceutical Services, Inc. Patient Controlled Injectors Major Business
Table 9. West Pharmaceutical Services, Inc. Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 10. West Pharmaceutical Services, Inc. SWOT Analysis
Table 11. West Pharmaceutical Services, Inc. Patient Controlled Injectors Product and Services
Table 12. West Pharmaceutical Services, Inc. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Roche Basic Information, Manufacturing Base and Competitors
Table 14. Roche Patient Controlled Injectors Major Business
Table 15. Roche Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 16. Roche SWOT Analysis
Table 17. Roche Patient Controlled Injectors Product and Services
Table 18. Roche Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Unilife Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Unilife Corporation Patient Controlled Injectors Major Business
Table 21. Unilife Corporation Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 22. Unilife Corporation SWOT Analysis
Table 23. Unilife Corporation Patient Controlled Injectors Product and Services
Table 24. Unilife Corporation Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sensile Medical Basic Information, Manufacturing Base and Competitors
Table 26. Sensile Medical Patient Controlled Injectors Major Business
Table 27. Sensile Medical Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 28. Sensile Medical SWOT Analysis
Table 29. Sensile Medical Patient Controlled Injectors Product and Services
Table 30. Sensile Medical Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Westbourne Medical Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. Westbourne Medical Ltd. Patient Controlled Injectors Major Business
Table 33. Westbourne Medical Ltd. Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 34. Westbourne Medical Ltd. SWOT Analysis
Table 35. Westbourne Medical Ltd. Patient Controlled Injectors Product and Services
Table 36. Westbourne Medical Ltd. Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Janssen Pharmaceutical (Johnson & Johnson) Basic Information, Manufacturing Base and Competitors
Table 38. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Major Business
Table 39. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Total Revenue (USD Million) (2018-2019)
Table 40. Janssen Pharmaceutical (Johnson & Johnson) SWOT Analysis
Table 41. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Product and Services
Table 42. Janssen Pharmaceutical (Johnson & Johnson) Patient Controlled Injectors Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Patient Controlled Injectors Sales by Manufacturer (2018-2019) (K Units)
Table 44. Global Patient Controlled Injectors Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Patient Controlled Injectors Sales by Regions (2015-2020) (K Units)
Table 46. Global Patient Controlled Injectors Sales Market Share by Regions (2015-2020)
Table 47. Global Patient Controlled Injectors Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Patient Controlled Injectors Sales by Countries (2015-2020) (K Units)
Table 49. North America Patient Controlled Injectors Sales Market Share by Countries (2015-2020)
Table 50. North America Patient Controlled Injectors Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Patient Controlled Injectors Revenue Market Share by Countries (2015-2020)
Table 52. Europe Patient Controlled Injectors Sales by Countries (2015-2020) (K Units)
Table 53. Europe Patient Controlled Injectors Sales Market Share by Countries (2015-2020)
Table 54. Europe Patient Controlled Injectors Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Patient Controlled Injectors Sales by Regions (2015-2020) (K Units)
Table 56. Asia-Pacific Patient Controlled Injectors Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Patient Controlled Injectors Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Patient Controlled Injectors Sales by Countries (2015-2020) (K Units)
Table 59. South America Patient Controlled Injectors Sales Market Share by Countries (2015-2020)
Table 60. South America Patient Controlled Injectors Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Patient Controlled Injectors Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Patient Controlled Injectors Sales by Countries (2015-2020) (K Units)
Table 63. Middle East & Africa Patient Controlled Injectors Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Patient Controlled Injectors Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Patient Controlled Injectors Revenue Market Share by Countries (2015-2020)
Table 66. Global Patient Controlled Injectors Sales by Type (2015-2020) (K Units)
Table 67. Global Patient Controlled Injectors Sales Share by Type (2015-2020)
Table 68. Global Patient Controlled Injectors Revenue by Type (2015-2020) (USD Million)
Table 69. Global Patient Controlled Injectors Revenue Share by Type (2015-2020)
Table 70. Global Patient Controlled Injectors Sales by Application (2015-2020) (K Units)
Table 71. Global Patient Controlled Injectors Sales Share by Application (2015-2020)
Table 72. Global Patient Controlled Injectors Sales Forecast by Regions (2021-2025) (K Units)
Table 73. Global Patient Controlled Injectors Market Share Forecast by Regions (2021-2025)
Table 74. Global Patient Controlled Injectors Sales Forecast by Type (2021-2025) (K Units)
Table 75. Global Patient Controlled Injectors Market Share Forecast by Type (2021-2025)
Table 76. Global Patient Controlled Injectors Sales Forecast by Application (2021-2025)
Table 77. Global Patient Controlled Injectors Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Patient Controlled Injectors Picture
Figure 2. Global Sales Market Share of Patient Controlled Injectors by Type in 2019
Figure 3. Electronical Injectors Picture
Figure 4. Mechanical Injectors Picture
Figure 5. Others Picture
Figure 6. Patient Controlled Injectors Sales Market Share by Application in 2018
Figure 7. Cancer Treatment Picture
Figure 8. Auto-immune Treatment Picture
Figure 9. Blood Disorders Treatment Picture
Figure 10. Others Picture
Figure 11. Global Patient Controlled Injectors Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Patient Controlled Injectors Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Patient Controlled Injectors Sales Market Share by Manufacturer in 2019
Figure 32. Global Patient Controlled Injectors Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Patient Controlled Injectors Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Patient Controlled Injectors Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Patient Controlled Injectors Revenue Market Share by Regions (2015-2020)
Figure 39. Global Patient Controlled Injectors Revenue Market Share by Regions in 2018
Figure 40. North America Patient Controlled Injectors Sales and Growth Rate (2015-2020)
Figure 41. Europe Patient Controlled Injectors Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Patient Controlled Injectors Sales and Growth Rate (2015-2020)
Figure 43. South America Patient Controlled Injectors Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Patient Controlled Injectors Sales and Growth Rate (2015-2020)
Figure 45. North America Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Patient Controlled Injectors Sales Market Share by Countries (2015-2020)
Figure 47. North America Patient Controlled Injectors Sales Market Share by Countries in 2018
Figure 48. North America Patient Controlled Injectors Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Patient Controlled Injectors Revenue Market Share by Countries in 2018
Figure 50. United States Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Patient Controlled Injectors Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Patient Controlled Injectors Revenue Market Share by Countries in 2019
Figure 56. Germany Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Patient Controlled Injectors Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Patient Controlled Injectors Revenue Market Share by Regions 2019
Figure 64. China Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Patient Controlled Injectors Sales Market Share by Countries in 2019
Figure 71. South America Patient Controlled Injectors Revenue Market Share by Countries in 2019
Figure 72. Brazil Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Patient Controlled Injectors Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Patient Controlled Injectors Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Patient Controlled Injectors Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Patient Controlled Injectors Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Patient Controlled Injectors Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Patient Controlled Injectors Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Patient Controlled Injectors Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Patient Controlled Injectors Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Patient Controlled Injectors Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Patient Controlled Injectors Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Patient Controlled Injectors Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Patient Controlled Injectors Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
放射性医薬品インジェクターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Radiopharmaceutical Injectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Radiopharmaceut…- ニードルレスインジェクターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Needleless Injectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Needleless Injectors mar…
- エアインジェクターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Air Injectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Air Injectors market report pro…
- オフボディウェアラブルインジェクターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Off-body Wearable Injectors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 自動インジェクターの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Automatic Injectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Automatic Injectors marke…